Percentage of cancer volume in biopsy cores is prognostic for prostate cancer death and overall survival in patients treated with dose-escalated external beam radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 83, Issue 3, 2012, Pages 940-946

  Vance, Sean M ^a   Stenmark, Matthew H ^a   Blas, Kevin ^a   Halverson, Schulyer ^a   Hamstra, Daniel A ^a   Feng, Felix Y ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Biopsy; Prognostic factors; Prostate cancer; Radiotherapy; Tumor length; Tumor percentage

Indexed keywords

CAUSE-SPECIFIC SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FREEDOM FROM BIOCHEMICAL FAILURES; GLEASON SCORES; HAZARD RATIO; HIGH-RISK PATIENTS; INDIVIDUAL RISKS; INTER QUARTILE RANGES; LOCALIZED PROSTATE CANCER; MULTI VARIATE ANALYSIS; NEEDLE BIOPSY; OVERALL SURVIVAL; PLANNING TARGET VOLUMES; PRE-TREATMENT; PROGNOSTIC FACTORS; PROSTATE CANCERS; PROSTATE SPECIFIC ANTIGEN; RISK STRATIFICATION;

BIOPSY; CORE LEVELS; PATHOLOGY; PATIENT MONITORING; PESTICIDE EFFECTS; RADIOTHERAPY; TUMORS; UROLOGY;

DISEASES;

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; CAUSE SPECIFIC SURVIVAL; EXTERNAL BEAM RADIOTHERAPY; FOLLOW UP; GLEASON SCORE; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEEDLE BIOPSY; ONCOLOGICAL PARAMETERS; OVERALL SURVIVAL; PERCENTAGE OF CANCER VOLUME; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE;

AGED; ANALYSIS OF VARIANCE; BIOPSY, NEEDLE; HUMANS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY, CONFORMAL; RADIOTHERAPY, INTENSITY-MODULATED; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84861581194     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.09.005     Document Type: Article

References (18)

1. A.V. D'Amico, R. Whittington, and S.B. Malkowicz Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JAMA 280 1998 969 974
2. M.R. Cooperberg, D.J. Pasta, and E.P. Elkin The University of California, San Francisco Cancer of the Prostate Risk Assessment score: A straightforward and reliable preoperative predictor of disease recurrence after radical prostatectomy J Urol 173 2005 1938 1942
3. Qian Y, Feng FY, Halverson S, et al. The percent of positive biopsy cores improves prediction of prostate cancer-specific death in patients treated with dose-escalated radiotherapy. Int J Radiat Oncol Biol Phys Epub 2011 Feb 23.
4. S.J. Freedland, W.J. Aronson, and G.S. Csathy Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: Results from the SEARCH database Urology 61 2003 742 747
5. S.J. Freedland, M.K. Terris, and G.S. Csathy Preoperative model for predicting prostate specific antigen recurrence after radical prostatectomy using percent of biopsy tissue with cancer, biopsy Gleason grade and serum prostate specific antigen J Urol 171 2004 2215 2220
6. M.B. Gretzer, J.I. Epstein, and C.R. Pound Substratification of stage T1c prostate cancer based on the probability of biochemical recurrence Urology 60 2002 1034 1039
7. P.W. Linson, A.K. Lee, and T. Doytchinova Percentage of core lengths involved with prostate cancer: Does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer? Urology 59 2002 704 708
8. C.P. Nelson, R.L. Dunn, and J.T. Wei Contemporary preoperative parameters predict cancer-free survival after radical prostatectomy: A tool to facilitate treatment decisions Urol Oncol 21 2003 213 218
9. C.P. Nelson, M.A. Rubin, and M. Strawderman Preoperative parameters for predicting early prostate cancer recurrence after radical prostatectomy Urology 59 2002 740 746
10. V. Ravery, C. Chastang, and M. Toublanc Percentage of cancer on biopsy cores accurately predicts extracapsular extension and biochemical relapse after radical prostatectomy for T1-T2 prostate cancer Eur Urol 37 2000 449 455
11. T.J. Sebo, J.C. Cheville, and D.L. Riehle Perineural invasion and MIB-1 positivity in addition to Gleason score are significant preoperative predictors of progression after radical retropubic prostatectomy for prostate cancer Am J Surg Pathol 26 2002 431 439
12. L. Potters, R. Purrazzella, and S. Brustein A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma Cancer 95 2002 1451 1456
13. J. Cuzick, G. Fisher, and M.W. Kattan Long-term outcome among men with conservatively treated localised prostate cancer Br J Cancer 95 2006 1186 1194
14. M.K. Buyyounouski, A.L. Hanlon, and E.M. Horwitz Pretreatment risk stratification of prostate cancer with percent positive prostate biopsy tissue obviates the need for clinical staging and identifies high grade disease suitable for treatment without androgen deprivation Int J Radiat Oncol Biol Phys 60 2004 S433-S433
15. P. Harnden, M.D. Shelley, and B. Naylor Does the extent of carcinoma in prostatic biopsies predict prostate-specific antigen recurrence? A systematic review Eur Urol 54 2008 728 739
16. R.T. Vollmer Tumor length in prostate cancer Am J Clin Pathol 130 2008 77 82
17. R.T. Vollmer Percentage of tumor and tumor length in prostate biopsy specimens: A study of American veterans Am J Clin Pathol 130 2008 940 943
18. M. Roach III, G. Hanks, and H. Thames Jr. Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: Recommendations of the RTOG-ASTRO Phoenix Consensus Conference Int J Radiat Oncol Biol Phys 65 2006 965 974